Skip to content
2000
Volume 18, Issue 6
  • ISSN: 1570-193X
  • E-ISSN: 1875-6298

Abstract

New drugs introduced in the market each year, have privileged structures specifically for anticancer targets, of which quinoline-based analogues also play an important role. This review highlights quinoline and its derivatives, which have great potency against various cancer cells, including prostate cancer, breast cancer, colon cancer, pancreas cancer, and many more. This review describes the most preferred process-scale synthetic approaches of quinoline and its derivatives having a specific pharmacophore for anticancer targets. It also describes the undergoing development and recently approved drugs in tabular form. Quinoline moiety as a privileged structural pharmacophore has the most effective activity against different cancer cell lines like prostate cancer, breast cancer, stomach cancer, pancreas cancer, Colon cancer, CNS cancer, and renal cancer. It can be used as a lead compound for further research on anticancer drug discovery.

Loading

Article metrics loading...

/content/journals/mroc/10.2174/1570193X17999201012182001
2021-09-01
2025-07-13
Loading full text...

Full text loading...

/content/journals/mroc/10.2174/1570193X17999201012182001
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test